M. Levi and T. Van-der-poll, Two-way interactions between inflammation and coagulation, Trends Cardiovasc Med, vol.15, pp.254-259, 2005.

C. T. Esmon, The impact of the inflammatory response on coagulation, Thromb Res, vol.114, pp.321-327, 2004.

T. Minami, A. Sugiyama, S. Q. Wu, R. Abid, T. Kodama et al., Thrombin and phenotypic modulation of the endothelium, Arterioscler Thromb Vasc Biol, vol.24, pp.41-53, 2004.

C. Sapet, S. Simoncini, B. Loriod, D. Puthier, J. Sampol et al., Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2, Blood, vol.108, pp.1868-1876, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01595821

B. Hugel, M. Carmen, M. C. Martinez, C. Kunzelmann, and J. M. Freyssinet, Membrane microparticles: two sides of the coin, Physiology, vol.20, pp.22-27, 2005.

V. Combes, A. C. Simon, G. E. Grau, D. Arnoux, L. Camoin et al., In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant, J Clin Invest, vol.104, pp.93-102, 1999.

F. Sabatier, V. Roux, F. Anfosso, L. Camoin, J. Sampol et al., Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity, Blood, vol.99, pp.3962-3970, 2002.

R. Lacroix, F. Sabatier, A. Mialhe, A. Basire, R. Pannell et al., Activation of plasminogen into plasmin at the surface of endothelial microparticles, Blood, vol.110, pp.2432-2439, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00160595

G. Taraboletti, D. 'ascenzo, S. Borsotti, P. Giavazzi, R. Pavan et al., Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells, Am J Pathol, vol.160, pp.673-680, 2002.

F. Sabatier, P. Darmon, B. Hugel, V. Combes, M. Sanmarco et al., Type 1 and type 2 diabetic patients display different patterns of cellular microparticles, Diabetes, vol.51, pp.2840-2845, 2002.

F. Dignat-george, L. Camoin-jau, F. Sabatier, D. Arnoux, F. Anfosso et al., Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome, Thromb Haemost, vol.91, pp.667-673, 2004.

V. Faure, L. Dou, F. Sabatier, C. Cerini, J. Sampol et al., Elevation of circulating endothelial microparticles in patients with chronic renal failure, J Thromb Haemost, vol.4, pp.566-573, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01610442

A. S. Shet, O. Aras, K. Gupta, M. J. Hass, D. J. Rausch et al., Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes, Blood, vol.102, pp.2678-2683, 2003.

L. Bernal-mizrachi, W. Jy, C. Fierro, R. Macdonough, H. A. Velazques et al., Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes, Int J Cardiol, vol.97, pp.439-446, 2004.

E. Svedas, H. Nisell, M. J. Vanwijk, Y. Nikas, and K. R. Kublickiene, Endothelial dysfunction in uterine circulation in preeclampsia, Am J Obstet Gynecol, vol.187, pp.1608-1616, 2002.

U. Schaefer, O. Voloshanenko, D. Willen, and H. Walczak, TRAIL: a multifunctional cytokine, Front Biosc, vol.12, pp.3813-3824, 2007.

G. Zauli and P. Secchiero, The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology, Cytokine Growth Factor Rev, vol.17, pp.245-257, 2006.

F. C. Kimberley and G. R. Screaton, Following a TRAIL: update on a ligand and its five receptors, Cell Res, vol.14, pp.359-372, 2004.

E. Varfolomeev, H. Maecker, D. Sharp, D. Lawrence, M. Renz et al., Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing Ligand, J Biol Chem, vol.280, pp.40599-40608, 2005.

W. C. Aird, Phenotypic heterogeneity of the endothelium, Circ Res, vol.100, pp.158-173, 2007.

A. Greinacher and T. E. Warkentin, The direct thrombin inhibitor hirudin, Thromb Haemost, vol.99, pp.819-829, 2008.

S. Q. Wu, W. C. Aird, and . Thrombin, TNF-{alpha}, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells, Am J Physiol Heart Circ Physiol, vol.289, pp.873-885, 2005.

F. Muhlenbeck, P. Schneider, J. L. Bodmer, R. Schwenzer, A. Hauser et al., The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation, J Biol Chem, vol.275, pp.32208-32213, 2000.

H. Wajant, D. Moosmayer, T. Wuest, T. Bartke, E. Gerlach et al., Differential activation of TRAIL-R1 and-2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative, Oncogene, vol.20, pp.4101-4106, 2001.

A. A. Kuang, G. E. Diehl, J. K. Zhang, and A. Winoto, FADD is required for DR4-and DR5-mediated apoptosis, J Biol Chem, vol.275, pp.25065-25068, 2000.

P. Schneider, M. Thome, K. Burns, J. L. Bodmer, K. Hofmann et al., TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-B, Immunity, vol.7, pp.831-836, 1997.

M. A. Kelliher, S. Grimm, Y. Ishida, F. Kuo, B. Z. Stanger et al., The death domain kinase RIP mediates the TNF-induced NF-kappa B signal, Immunity, vol.8, pp.297-303, 1998.

N. Harper, S. N. Farrow, A. Kaptein, G. M. Cohen, and M. Macfarlane, Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases, J Biol Chem, vol.276, pp.34743-34752, 2001.

H. Wajant, TRAIL and NFB signaling-a complex relationship, Vitam Horm, vol.67, pp.103-132, 2004.

D. Aranther, M. T. Millan, A. Palmetshofer, S. C. Robson, C. Geczy et al., Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF, J Immunol, vol.159, pp.5620-5628, 1997.

G. Kaplanski, M. Fabrigoule, V. Boulay, C. A. Dinarello, P. Bongrand et al., Thrombin induces endothelial type II activation in vitro, J Immunol, vol.158, pp.5435-5441, 1997.

J. H. Li, N. C. Kirkiles-smith, J. M. Mcniff, and J. S. Pober, TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells, J Immunol, vol.171, pp.1526-1533, 2003.

T. Wachter, M. Sprick, D. Hausmann, A. Kerstan, K. Mcpherson et al., cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes, J Biol Chem, vol.279, pp.52824-52834, 2004.

B. Chaudhari, R. Murphy, and D. Agrawal, Following the TRAIL to apoptosis, Immunol Res, vol.35, pp.249-262, 2006.

P. Secchiero, A. Gonelli, E. Carnevale, D. Milani, A. Pandolfi et al., TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways, Circulation, vol.107, pp.2250-2256, 2003.

P. Secchiero, A. Gonelli, E. Carnevale, F. Corallini, C. Rizzardi et al., Evidence for a proangiogenic activity of TNFrelated apoptosis-inducing ligand, Neoplasia, vol.6, pp.364-373, 2004.

L. A. O'brien, M. A. Richardson, S. F. Mehrbod, D. T. Berg, B. Gerlitz et al., Activated protein c decreases tumor necrosis factor-related apoptosis-inducing ligand by an EPCR-Independent mechanism involving Egr-1/Erk-1/2 activation, Arterioscler Thromb Vasc Biol, vol.27, pp.2634-2641, 2007.

P. Chen and E. A. , Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation, J Vasc Res, vol.45, pp.111-122, 2007.

J. L. Martin-ventura, B. Munoz-garcia, J. Egido, and L. M. Blanco-colio, TRAIL and vascular injury. Front Biosc, vol.12, pp.3656-3667, 2007.

M. N. Lub-de-hooge, E. De-vries, S. De-jong, and M. Bijl, Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus, Ann Rheum Dis, vol.64, pp.854-858, 2005.

M. N. Lub-de-hooge, S. De-jong, C. Vermot-desroches, J. E. Tulleken, E. De-vries et al., Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway, Shock, vol.22, pp.186-188, 2004.

J. Morel, R. Audo, M. Hahne, and B. Combe, Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt, J Biol Chem, vol.280, pp.15709-15718, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02262258

R. J. Berckmans, R. Nieuwland, P. P. Tak, A. N. Boing, F. Romijn et al., Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism, Arthr Rheum, vol.46, pp.2857-2866, 2002.

A. O. Soriano, W. C. Jy, J. A. Chirinos, M. A. Valdivia, H. S. Velasquez et al., Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis, Crit Care Med, vol.33, pp.2540-2546, 2005.

M. J. Vanwijk, E. Vanbavel, A. Sturk, and R. Nieuwland, Microparticles in cardiovascular diseases, Cardiovasc Res, vol.59, pp.277-287, 2003.

Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J. M. Freyssinet et al., Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques, Circulation, vol.99, pp.348-353, 1999.

A. S. Leroyer, H. Isobe, G. Leseche, Y. Castier, M. Wassef et al., Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques, J Am Coll Cardiol, vol.49, pp.772-777, 2007.

M. M. Kavurma and M. R. Bennett, Expression, regulation and function of trail in atherosclerosis, Biochem Pharmacol, vol.75, pp.1441-1450, 2008.

Y. Michowitz, E. Goldstein, A. Roth, A. Afek, A. Abashidze et al., The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis, J Am Coll Cardiol, vol.45, pp.1018-1024, 2005.

M. Schoppet, A. M. Sattler, J. R. Schaefer, and L. C. Hofbauer, Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis, Atherosclerosis, vol.184, pp.446-447, 2006.